Company intelligence / Profile preview

Phiderma

Montreal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

Phiderma is a Canadian healthcare company specializing in the development and distribution of advanced aesthetic medicine and dermatological solutions. Headquartered in Montreal, the company offers a comprehensive portfolio of products including hyaluronic acid-based dermal fillers, professional chemical peels, mesotherapy solutions, and specialized dermo-cosmetic skincare. Phiderma focuses on providing non-surgical corrective and anti-aging treatments to healthcare professionals, primarily targeting skin rejuvenation and the restoration of facial volume. Their business model integrates research-driven product formulation with a global distribution network to serve the medical aesthetics market.

Therapeutic areas: Dermatology
Modalities: Small moleculeBiologicDevice
Industry: Biotech

Beyond the preview

Go deeper on Phiderma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phiderma.

Explore the full profile